Physician Wealth Advisors Inc. Acquires 297 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Physician Wealth Advisors Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 74.6% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 695 shares of the healthcare conglomerate’s stock after purchasing an additional 297 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $326,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Waverly Advisors LLC increased its holdings in shares of UnitedHealth Group by 8.7% in the 3rd quarter. Waverly Advisors LLC now owns 5,088 shares of the healthcare conglomerate’s stock valued at $2,565,000 after acquiring an additional 407 shares during the period. Hodges Capital Management Inc. purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at $1,127,000. Kidder Stephen W increased its holdings in shares of UnitedHealth Group by 10.0% in the 3rd quarter. Kidder Stephen W now owns 13,771 shares of the healthcare conglomerate’s stock valued at $6,943,000 after acquiring an additional 1,251 shares during the period. Gateway Advisory LLC grew its stake in UnitedHealth Group by 2.5% during the 3rd quarter. Gateway Advisory LLC now owns 9,399 shares of the healthcare conglomerate’s stock worth $4,739,000 after buying an additional 226 shares during the last quarter. Finally, Provident Investment Management Inc. grew its stake in UnitedHealth Group by 3.9% during the 3rd quarter. Provident Investment Management Inc. now owns 88,459 shares of the healthcare conglomerate’s stock worth $44,600,000 after buying an additional 3,347 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Price Performance

NYSE UNH traded up $22.82 during trading hours on Friday, reaching $509.26. The company’s stock had a trading volume of 22,734,197 shares, compared to its average volume of 3,685,941. The firm has a market capitalization of $468.72 billion, a price-to-earnings ratio of 31.13, a P/E/G ratio of 1.41 and a beta of 0.58. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The company’s 50-day moving average is $498.34 and its two-hundred day moving average is $501.96.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. UnitedHealth Group’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.26 EPS. On average, equities analysts predict that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were paid a dividend of $2.10 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date was Monday, June 17th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Robert W. Baird initiated coverage on UnitedHealth Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $597.00 target price on the stock. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research report on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target for the company in a research report on Wednesday, June 5th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.